Abetalipoproteinemia is a rare genetic condition that affects how the body absorbs and transports fats and fat‑soluble vitamins. It usually starts in infancy with poor weight gain, greasy stools, and later balance or vision problems. People with abetalipoproteinemia often have lifelong features like fatigue, tingling in the feet, trouble walking, and night blindness as vitamin E and A levels fall. Treatment focuses on a very low‑fat diet and high‑dose vitamins A, E, K, and sometimes D, and many people do better with early care. The outlook varies, but early diagnosis and steady treatment can reduce complications and support long, active lives.
Overview
AbetalipoproteinemiaSymptoms
Abetalipoproteinemia features often start in infancy with trouble absorbing fats: chronic diarrhea, pale greasy stools, vomiting, and poor weight gain. Later, some develop numbness, unsteady walking, muscle weakness, and vision problems in low light.
Outlook and prognosis
Many living with abetalipoproteinemia do well long term when it’s identified early and treated consistently. High‑dose fat‑soluble vitamins, careful nutrition, and regular eye and nerve checks can slow or stabilize vision loss, balance problems, and growth issues. Close follow-up helps maintain independence.
Causes and risk factors
Abetalipoproteinemia is caused by changes in the MTTP gene that stop the body making key fat-carrying particles. It’s inherited recessively—risk is highest when both parents are carriers, especially if related. Diet and early fat‑soluble vitamins can lessen complications.
Genetic influences
Genetics are central in abetalipoproteinemia: it’s caused by inherited changes in the MTTP gene. Most people inherit one variant from each parent (autosomal recessive). Different variants can influence age at onset, severity, and response to fat-soluble vitamin therapy.
Diagnosis
Doctors suspect abetalipoproteinemia from clinical features like fat malabsorption, very low LDL/cholesterol, and acanthocytes on a blood smear. The diagnosis of Abetalipoproteinemia is confirmed with genetic tests for MTTP variants; supportive tests may measure fat-soluble vitamins and apoB-lipoproteins.
Treatment and drugs
Abetalipoproteinemia treatment focuses on lifelong high‑dose fat‑soluble vitamins (A, D, E, K) and careful nutrition. Many follow a very low–long‑chain‑fat diet with added medium‑chain triglycerides. Regular monitoring helps protect vision, nerves, growth, and liver health.
Symptoms
Day to day, Abetalipoproteinemia often first shows up as trouble digesting fats, slow weight gain, and oily stools in infancy or childhood. You might notice small changes at first, then later issues with balance, numbness, or night vision. These features come from very low levels of fat‑soluble vitamins and the body’s difficulty moving fats through the bloodstream. Spotting the early features of Abetalipoproteinemia can help with timely care.
Stools may look pale, oily, and hard to flush. They can smell stronger than usual and may leave a film in the toilet.
Babies may not gain weight as expected even with regular feeds. Older children may stay smaller or leaner than peers.
Loose stools can occur often, especially after fatty foods. Belly bloating, cramps, and gas are common.
Walking can feel unsteady, and tasks like buttoning or handwriting can get harder. In Abetalipoproteinemia, low vitamin E affects the nerves and balance centers.
How people usually first notice Abetalipoproteinemia?
Many families first notice abetalipoproteinemia in infancy when a baby has trouble gaining weight despite feeding, has frequent, greasy, difficult-to-flush stools (steatorrhea), and seems unusually tired or weak. As toddlers, some develop balance problems or a wobbly walk, and doctors may see very low levels of “bad” cholesterol (LDL) and triglycerides on a blood test, which points to fat and fat‑soluble vitamin absorption problems—the classic first signs of abetalipoproteinemia. In some cases, an abnormal newborn screen, poor growth, or pale stools prompts earlier evaluation, leading to how abetalipoproteinemia is first noticed.
Types of Abetalipoproteinemia
Abetalipoproteinemia has a single underlying cause—faults in the MTTP gene—that disrupt the body’s ability to make certain fat-carrying particles. There aren’t widely accepted subtypes the way some conditions have clear-cut variants. People with abetalipoproteinemia can still look quite different in how early symptoms start and how severe they are, often depending on diet, age at diagnosis, and vitamin support. Not everyone will experience every type.
No distinct types
No distinct types of abetalipoproteinemia are widely recognized. Differences you may hear about usually reflect severity and age at diagnosis rather than true variants. This means discussions about types of abetalipoproteinemia often focus on presentation, not genetics.
What genetics can tell you about symptoms
Some people with abetalipoproteinemia who inherit two APOB or MTTP gene changes develop fat‑soluble vitamin deficiencies, leading to night blindness, unsteady walking, and muscle weakness. Others show early greasy, foul‑smelling stools and poor growth because impaired lipoprotein formation blocks fat absorption.
Causes and risk factors
Abetalipoproteinemia is caused by inheriting two nonworking copies of the MTTP gene. This gene change stops the body from forming the particles that carry fats and fat-soluble vitamins. Some risks are modifiable (things you can change), others are non-modifiable (things you can’t). Non-modifiable risks include having carrier parents, a family history, related parents, or ancestry from a group with higher carrier rates. Modifiable factors like diet and fat-soluble vitamin intake do not cause the disease, but they can shape the severity and timing of early symptoms of abetalipoproteinemia.
Environmental and biological risk factors
Abetalipoproteinemia is present from birth, so many wonder what in the body or environment might raise the chance of it occurring. Doctors often group risks into internal (biological) and external (environmental). Clear, strong environmental triggers have not been identified for abetalipoproteinemia, and most routine pregnancy or birth factors don’t appear to shift the odds. People may notice early symptoms of abetalipoproteinemia in infancy, but the points below focus only on potential environmental and biological influences.
Older maternal age has not been shown to raise the chance of abetalipoproteinemia. Unlike conditions tied to chromosome changes, this condition does not show a maternal age pattern.
Advanced paternal age has not been linked to higher risk for abetalipoproteinemia. Current data do not show a consistent pattern.
Common maternal conditions such as diabetes, high blood pressure, or thyroid problems have not been shown to cause the condition. Typical prenatal illnesses are not known to alter risk.
Contact with radiation, heavy metals, or industrial solvents has not been shown to increase the likelihood of abetalipoproteinemia. Evidence for an exposure-related risk is lacking.
Genetic risk factors
When the genes behind Abetalipoproteinemia don’t work as expected, the body can’t assemble the fat-carrying particles it needs, and early symptoms of Abetalipoproteinemia can appear in the first months of life. Some risk factors are inherited through our genes. This condition follows an autosomal recessive pattern, typically appearing only when both copies of a key gene are changed. Genetic testing can confirm the specific changes and clarify risks for relatives.
MTTP gene changes: Harmful changes in the MTTP gene disrupt the MTP protein needed to build lipoproteins (fat-carrying particles). Without these particles, fats and certain vitamins can’t move normally into the blood. This direct gene effect causes Abetalipoproteinemia.
Recessive inheritance: Abetalipoproteinemia appears when a child inherits two nonworking MTTP copies, one from each parent. Parents with one changed copy are usually healthy carriers. If both are carriers, each pregnancy has a 25% (1 in 4) chance to be affected.
Carrier status: Carriers typically have no symptoms. They can pass the MTTP change on, so risk to their children depends on whether their partner is also a carrier. Carrier testing can identify this before or during pregnancy.
Family history: Having an affected sibling or known MTTP changes in the family means a higher chance another child could be affected. Unaffected full siblings of a person with this condition have about a 2 in 3 chance to be carriers. Extended relatives may also be carriers without knowing it.
Parental relatedness: When parents are related by blood (for example, cousins), they are more likely to share the same rare MTTP change. This raises the chance that a child will inherit two changed copies. Genetic counseling can help families understand these odds.
Variant differences: Not all MTTP changes act the same way. Some leave a small amount of protein activity, which can influence how early Abetalipoproteinemia shows and how severe it is. Severity can differ even within one family.
Lifestyle risk factors
Abetalipoproteinemia is a genetic condition; lifestyle habits do not cause it, but they can influence symptoms, growth, and complications. Paying attention to diet, supplements, and daily activities can help manage digestion, liver health, bone strength, and neurologic and vision issues. The lifestyle risk factors for Abetalipoproteinemia center on how meals, supplements, and activity patterns affect nutrient absorption and organ health. Below are examples of how lifestyle affects Abetalipoproteinemia in everyday life.
Large amounts of long-chain fats can worsen diarrhea and fat malabsorption, increasing vitamin deficiencies. Choosing lower long-chain fat and avoiding large, greasy meals may reduce GI symptoms and improve nutrient uptake.
Relying on medium-chain triglycerides can provide calories without worsening fat malabsorption. Skipping or underusing MCTs may lead to poor weight gain and low energy.
Missing high-dose vitamins A, D, E, and K can accelerate neuropathy, vision problems, and bone disease. Consistent, clinician-directed dosing (often with specialized formulations) helps protect nerves, retina, and skeleton.
Long gaps between meals can aggravate fatigue and make GI symptoms harder to manage. Small, frequent meals may improve comfort and nutrient delivery.
Risk prevention
Abetalipoproteinemia is inherited, so the condition itself can’t be fully prevented. Early diagnosis and targeted care can lower the chance of long-term problems with vision, nerves, growth, and the liver. Even if you can’t remove all risks, prevention can reduce their impact. Daily nutrition changes and vitamin therapy are the core, backed by regular check-ups.
Ask about carrier testing, options for future pregnancies, and testing for siblings. This helps families understand chances of passing on abetalipoproteinemia and plan care early.
High-dose fat-soluble vitamins (A, D, E, and K) support eye, nerve, bone, and blood health. In abetalipoproteinemia, these vitamins do not absorb well without careful dosing and monitoring.
Limit long-chain fats and use medium-chain triglycerides (MCTs) for calories that absorb more easily. A dietitian can help you meet energy and protein needs while protecting vitamin levels.
Regular eye exams can catch early symptoms of abetalipoproteinemia such as night blindness or trouble with dark adaptation. Adjusting vitamin A and E early may help protect vision.
Transmission
Abetalipoproteinemia is not contagious; it cannot be spread through touch, coughing, blood, or sex.
Abetalipoproteinemia is inherited in a recessive way: a child must receive two nonworking copies of the gene, one from each parent who usually has no symptoms (a carrier). When both parents are carriers, each pregnancy has a 25% (1 in 4) chance of a child with Abetalipoproteinemia, a 50% (1 in 2) chance of a carrier child, and a 25% chance of a child who is neither affected nor a carrier. New, spontaneous changes in the gene can cause the condition even without a known family history, though this is uncommon. A genetics professional can explain how Abetalipoproteinemia is inherited and discuss carrier testing and family planning options.
When to test your genes
Consider genetic testing if you or a close relative had abetalipoproteinemia, especially with fat‑soluble vitamin deficiencies, failure to thrive, steatorrhea, or early neurologic or vision changes. Testing helps confirm the diagnosis early, guide high‑dose vitamins A, D, E, K, and nutrition, and screen siblings. Preconception or prenatal testing is useful for at‑risk couples.
Diagnosis
Many families first notice feeding difficulties, greasy stools, or poor weight gain in infancy, or later problems like unsteady walking or night vision changes. These clues usually lead to testing for rare disorders of fat absorption and vitamin transport, including Abetalipoproteinemia. Doctors confirm the diagnosis of Abetalipoproteinemia by combining clinical findings with focused blood tests and genetic testing. Finding out the cause is the first step toward treatment.
Providers look for early problems such as greasy stools, poor weight gain, and bloating in infancy. Later features can include trouble with balance, reduced reflexes, and night vision changes. These patterns raise concern for Abetalipoproteinemia.
Blood tests often show very low total cholesterol and triglycerides. LDL levels are typically near zero, reflecting absent transport particles. HDL may be normal or low but is less informative for this condition.
A blood test measures apoB, the key protein for LDL and VLDL. In Abetalipoproteinemia, apoB is usually undetectable or extremely low. This finding strongly supports the diagnosis.
A simple microscope check of blood can show spiky red cells called acanthocytes. Their presence is common in Abetalipoproteinemia. It helps distinguish this condition from other causes of low cholesterol.
Stages of Abetalipoproteinemia
Abetalipoproteinemia does not have defined progression stages. It often appears in infancy or childhood with trouble absorbing fats, and later nerve and vision changes can develop, but the timing and severity vary and are greatly shaped by how early high-dose vitamin treatment begins. Different tests may be suggested to help confirm the diagnosis, including blood work showing very low LDL cholesterol and triglycerides, stool tests for fat, and genetic testing; eye and nerve checks are used to monitor changes over time. If you’re watching for early symptoms of abetalipoproteinemia, let your doctor know about chronic diarrhea, poor growth, unusual fatigue, or balance or night-vision problems, as these can guide testing and follow-up.
Outlook and prognosis
Looking ahead can feel daunting, but many people with Abetalipoproteinemia can lead meaningful, engaged lives with the right care. Prognosis refers to how a condition tends to change or stabilize over time. For this condition, outcomes vary based on how early it’s diagnosed, how well nutrition is managed, and whether complications like vision, nerve, or liver problems are prevented or slowed.
Early care can make a real difference, especially when high-dose fat‑soluble vitamins (A, D, E, K) and careful nutrition start in childhood. With consistent treatment, many living with Abetalipoproteinemia maintain mobility longer, protect vision for more years, and keep heart and liver health more stable. Some people experience milder progression, while others notice faster changes in balance, muscle strength, or eyesight if treatment starts late or isn’t well tolerated.
Severe, untreated Abetalipoproteinemia can shorten life expectancy due to complications such as advanced vision loss, disabling neuropathy, serious malnutrition, or liver disease. When doctors talk about “remission,” they mean symptoms have eased or disappeared for a while. That said, modern care has improved the long-term outlook, and early symptoms of Abetalipoproteinemia—like poor weight gain, greasy stools, or balance issues—are now recognized sooner in many clinics. Talk with your doctor about what your personal outlook might look like.
Long-term effects
Abetalipoproteinemia can lead to health issues that unfold over years, mainly due to long-lasting vitamin shortages and nerve and eye involvement. Long-term effects vary widely and can change from childhood into adulthood. Many remember early symptoms of abetalipoproteinemia starting in infancy, yet the long-term picture centers on nerve changes, vision loss, and growth challenges. How these unfold often depends on how strongly the nerves, eyes, liver, and bones are affected over time.
Ongoing injury to peripheral nerves can cause numbness, tingling, and weakness in the hands and feet. Reflexes may fade and muscle tone can drop as years pass.
Coordination often worsens over time, leading to an unsteady, wide-based walk. Some find precise hand movements more difficult as balance control declines.
The retina can slowly degenerate, first causing night blindness and then narrowing side vision. For some with abetalipoproteinemia, this progresses to significant vision loss in adulthood.
Long-standing nutrient gaps can lead to slow weight gain, short stature, and delayed puberty. Adults may remain smaller and leaner than peers.
How is it to live with Abetalipoproteinemia?
Living with abetalipoproteinemia often means planning ahead for meals, supplements, and checkups, because the body can’t absorb fat-soluble vitamins well and needs lifelong high-dose vitamins A, D, E, and K. Day to day, many notice greasy stools, fatigue, and balance or coordination challenges over time, and some develop vision or nerve problems if vitamins run low, so staying on top of nutrition and labs becomes part of the routine. Family members and friends may help with grocery choices, reminders for supplements, and transportation to appointments, and they may also adjust activities to support safe movement and reduce fall risk. With a knowledgeable care team and consistent treatment, many find a steady rhythm that protects vision and nerve function and keeps life’s plans moving forward.
Treatment and drugs
Treatment for abetalipoproteinemia focuses on replacing missing nutrients, protecting the nervous system and eyes, and preventing long-term complications. High-dose fat‑soluble vitamins are the cornerstones: vitamin E (often very high doses), plus vitamins A, D, and K, along with essential fatty acids; doctors monitor blood levels and eye, bone, and nerve health to fine‑tune doses. A very low‑fat diet, avoidance of long‑chain fats, and use of special medium‑chain triglycerides can improve nutrient absorption and reduce stomach issues, while careful nutrition support helps children grow and supports weight maintenance. Supportive care can make a real difference in how you feel day to day, including physiotherapy for balance and strength, vision care, and treatment of liver or blood problems if they arise. Your doctor may suggest regular follow‑up with a metabolic or genetics clinic, since treatment plans often combine several approaches and may change with age, pregnancy, or new symptoms.
Non-drug treatment
Daily care for abetalipoproteinemia centers on nutrition, therapies, and routines that protect the nerves, eyes, and growth. The goal is to improve nutrient absorption and reduce strain on the body, especially the liver and digestive system. Alongside medicines, non-drug therapies can make day-to-day life more comfortable and help prevent complications. Plans are tailored by age and symptoms, and often evolve as needs change.
A low long‑fat diet with added medium‑chain fats (MCT oil) is easier to absorb and helps with energy. This approach can reduce diarrhea and greasy stools while supporting growth.
A metabolic or gastrointestinal dietitian can personalize meals and snacks so you get enough calories, protein, and essential fats. They can adjust the plan if stools are oily or weight slips, and can flag early symptoms of abetalipoproteinemia that need attention.
Smaller, more frequent meals and careful pacing can ease bloating and cramping. Thickened liquids or texture changes may help if swallowing is hard.
A speech and swallow therapist can assess safety and teach techniques that make eating and drinking easier. Structured programs, like swallow exercises and posture training, can help reduce choking risk.
Your genes may have an impact on how drugs work for you
Some medicines used in abetalipoproteinemia, like fat-soluble vitamin supplements and dietary fat substitutes, can work differently depending on genes that affect absorption and metabolism. Genetic differences may guide dosing, choice of formulations, and monitoring for side effects or benefits.
Pharmacological treatments
Treatment focuses on replacing fat-soluble vitamins to protect nerves, eyes, and bones, plus targeted supplements when needed. Starting early helps prevent complications that can show up later in life for people living with abetalipoproteinemia. Not everyone responds to the same medication in the same way. Doses are individualized and levels are checked regularly to balance benefits and safety.
High-dose vitamin E helps protect nerves and the retina and is a cornerstone of care in abetalipoproteinemia. Water‑miscible or emulsified forms are often better absorbed. Dosing may be increased or lowered gradually to keep blood levels in a protective range.
Supports night vision and overall eye health, which can help limit early symptoms of abetalipoproteinemia. Too much can strain the liver or bones, so levels and liver tests are monitored.
Helps build and maintain strong bones when fat absorption is limited. Blood vitamin D and calcium are checked to avoid low levels or, less commonly, excess.
Improves blood clotting and can reduce easy bruising or bleeding. In urgent situations, it may be given by injection, then continued by mouth once stable.
Genetic influences
Abetalipoproteinemia is caused by changes in a gene called MTTP, which helps the body package and move certain fats from the intestine into the bloodstream. Some conditions are passed down through families (inherited disorders). Abetalipoproteinemia follows a recessive pattern: a child develops it only when they receive the nonworking gene copy from both parents, who are usually healthy carriers. When two carriers have a child, each pregnancy has a 25% chance the child will have Abetalipoproteinemia, a 50% chance the child will be a carrier, and a 25% chance of neither. A lab-based genetic test can look for MTTP changes and confirm the diagnosis, and it can help relatives understand their own risk. Knowing the genetic cause also helps explain why early symptoms of Abetalipoproteinemia often start in infancy and can guide planning for siblings and future pregnancies.
Is Abetalipoproteinemia genetic?
Genetics are central in abetalipoproteinemia: it’s caused by inherited changes in the MTTP gene. Most people inherit one variant from each parent (autosomal recessive). Different variants can influence age at onset, severity, and response to fat-soluble vitamin therapy.
Pharmacogenetics—how genetics influence drug effects
The specific change in a gene called MTTP shapes how doctors treat abetalipoproteinemia, guiding choices about diet, vitamins, and even which medicine forms are likely to work. Because the body can’t package fats normally, pills that rely on fat for absorption may not work as well; water‑soluble or injectable versions of vitamins A, D, E, and K are often used, with blood levels checked to fine‑tune dosing. Alongside medical history and nutrition planning, genetic testing helps confirm the cause and supports decisions about lifelong vitamin therapy and monitoring. In abetalipoproteinemia, cholesterol is already very low, so cholesterol‑lowering drugs are generally not recommended, and doses of other fat‑soluble medicines may need adjustment. Because the liver and nerves can be affected, care teams choose medicines thoughtfully and watch for side effects over time. For many families looking into how genetics influence treatment of abetalipoproteinemia, the takeaway is that the gene change steers supportive care rather than pointing to a single targeted drug.
Interactions with other conditions
Abetalipoproteinemia can interact with other diseases in ways that amplify nutrient shortages and symptoms. Conditions that reduce fat absorption—like celiac disease, Crohn’s disease involving the small intestine, chronic pancreatitis, or blocked bile flow (cholestasis)—can worsen shortages of vitamins A, D, E, and K, so vision changes, balance problems, muscle weakness, and easy bruising may intensify when another gut or liver issue is active. Liver problems such as fatty liver or viral hepatitis can add strain to a liver that already stores excess fat in abetalipoproteinemia, increasing the chance of inflammation or scarring. Nerve conditions that cause unsteady walking or numbness can overlap with the nerve damage from abetalipoproteinemia, and early symptoms of abetalipoproteinemia may be harder to spot if a second neurologic disorder is present. Bone fragility and bleeding issues can also be more pronounced when another bone or blood-clotting condition is in the mix because vitamin D and K levels are already low. Talk with your doctor about how your conditions may influence each other.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described infants who failed to gain weight, passed unusually greasy stools, and later developed unsteady walking and vision problems. Families and communities once noticed patterns of early digestive troubles followed by weakness in the limbs, not yet knowing these clues pointed to the same condition we now call abetalipoproteinemia. In some families, more than one child was affected, which hinted at something inherited long before genetics could explain it.
First described in the medical literature as a puzzling mix of fat malabsorption, acanthocytosis (spiky-looking red blood cells), and neurologic changes, abetalipoproteinemia slowly took shape as a distinct diagnosis in the mid-20th century. Early reports focused on the dramatic features doctors could see: pale, bulky stools; difficulty with balance; and eye findings consistent with retinitis pigmentosa. As clinicians followed children over years, they noticed that the digestive symptoms often appeared first, while nerve and vision problems developed gradually, especially when vitamins were low.
From early theories to modern research, the story of abetalipoproteinemia has been one of connecting scattered signs into a single cause. In the 1980s and 1990s, advances in genetics and protein chemistry identified the missing piece: a defect in a protein needed to assemble certain fat-carrying particles in the blood. This discovery explained why people with abetalipoproteinemia cannot absorb fat and fat-soluble vitamins well, and why early, high-dose vitamin therapy could change the course of the condition.
Over time, descriptions became more detailed, and the condition’s boundaries clearer. What was once considered rare is still uncommon, but better recognition means more children are diagnosed earlier, sometimes before severe nerve or eye complications begin. Historical differences highlight why early symptoms of abetalipoproteinemia—like poor weight gain, diarrhea, and very low cholesterol levels—matter for prompt testing and care.
In recent decades, awareness has grown around the importance of long-term follow-up and nutrition support. Clinicians learned from past cases that careful vitamin A, D, E, and K replacement and tailored fat intake could help protect the eyes and nervous system. Today, the history of abetalipoproteinemia guides a practical approach: watch closely in infancy, supplement early, and monitor vision and neurologic health over time. Looking back helps explain how early observation, family stories, and modern genetics together built the foundation for today’s treatment and support.